Emily S Gorell

7PUBLICATIONS
17CO-AUTHORS
Infant and child healthNeonatologyAdolescent healthBiologically active moleculesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 29, 2026
Characterization of TNF-Alpha Inhibitor Induced Paradoxical Psoriasiform Dermatitis at a Single Center via Retrospective Chart Review.

Muayad M Shahin, Emily S Gorell, Mariam Iqneibi

|Mar 04, 2025
Junctional Epidermolysis Bullosa With Pyloric Atresia Complicated by Esophageal Atresia and Nephrotic Syndrome: A Case Report and Review of the Literature.

Kennedy Sabharwal, Ianna Blanchard, Emily S Gorell

|Nov 20, 2024
A call to action to address transition of care in pediatric dermatology.

Elyse Mackenzie, Anne W Lucky, Emily S Gorell

|Jul 01, 2024
Evaluation of antipruritic effects of serlopitant, a neurokinin 1 receptor antagonist, in patients with epidermolysis bullosa: A phase 2 randomized controlled trial.

Utako Okata-Karigane, Pirunthan Pathmarajah, Emily S Gorell

|Oct 17, 2022
Long-term safety and efficacy of gene-corrected autologous keratinocyte grafts for recessive dystrophic epidermolysis bullosa.

Jodi Y So, Jaron Nazaroff, Chinonso V Iwummadu

|Sep 13, 2021
Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey.

Shivali Fulchand, Nicole Harris, Shufeng Li

Pageof 2

Frequent Collaborators

2 joint publications

Shivali Fulchand

2 joint publications

Mariam Iqneibi

1 joint publications

Dedee Murrell

1 joint publications

Jodi Y So